Variant report
Variant | nsv980559 |
---|---|
Chromosome Location | chr5:37917870-37922753 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:14)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:6)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:14 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr5:37918280-37918430 | BE2_C | brain: | n/a | n/a |
2 | E2F4 | chr5:37921669-37921869 | MCF10A-Er-Src | breast: | n/a | n/a |
3 | FOS | chr5:37921567-37921918 | MCF10A-Er-Src | breast: | n/a | n/a |
4 | FOS | chr5:37921586-37921895 | MCF10A-Er-Src | breast: | n/a | n/a |
5 | FOS | chr5:37921577-37921920 | MCF10A-Er-Src | breast: | n/a | n/a |
6 | FOS | chr5:37921549-37921937 | MCF10A-Er-Src | breast: | n/a | n/a |
7 | MYC | chr5:37921681-37922024 | MCF10A-Er-Src | breast: | n/a | n/a |
8 | MYC | chr5:37921597-37921918 | NB4 | blood: | n/a | n/a |
9 | MYC | chr5:37921639-37922165 | MCF10A-Er-Src | breast: | n/a | n/a |
10 | SETDB1 | chr5:37921623-37922005 | U2OS | brain: | n/a | n/a |
11 | STAT3 | chr5:37921639-37921875 | MCF10A-Er-Src | breast: | n/a | n/a |
12 | STAT3 | chr5:37921680-37921888 | MCF10A-Er-Src | breast: | n/a | n/a |
13 | STAT3 | chr5:37921597-37921941 | MCF10A-Er-Src | breast: | n/a | n/a |
14 | ZC3H11A | chr5:37921883-37921915 | K562 | blood: | n/a | n/a |
No data |
(count:3 , 50 per page) page:
1
(count:6 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-GDNF-1 | chr5:37918311-37918924 | NONHSAT101075 |
2 | lnc-GDNF-1 | chr5:37920056-37920199 | XLOC_004788 |
3 | lnc-GDNF-1 | chr5:37920933-37920971 | XLOC_004788 |
4 | lnc-GDNF-1 | chr5:37919842-37919892 | NONHSAT101075 |
5 | lnc-GDNF-1 | chr5:37920056-37920148 | NONHSAT101075 |
6 | lnc-GDNF-1 | chr5:37919842-37919892 | XLOC_004788 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000248539 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs559306280 | chr5:37917871-37917872 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs145651914 | chr5:37917887-37917888 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs56053960 | chr5:37917918-37917919 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs575864428 | chr5:37917991-37917992 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs10076420 | chr5:37917997-37917998 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs530669911 | chr5:37918004-37918005 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs149994278 | chr5:37918018-37918019 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs542253666 | chr5:37918024-37918025 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs139735966 | chr5:37918089-37918090 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs187517098 | chr5:37918109-37918110 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs76042028 | chr5:37918119-37918120 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs377204242 | chr5:37918156-37918157 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs557904124 | chr5:37918174-37918175 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs546461920 | chr5:37918175-37918176 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs369821689 | chr5:37918186-37918187 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs73075575 | chr5:37918215-37918216 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs532160652 | chr5:37918249-37918250 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs1423434 | chr5:37918253-37918254 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs569251022 | chr5:37918279-37918280 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs536705765 | chr5:37918297-37918298 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs78671305 | chr5:37918303-37918304 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs147603517 | chr5:37918324-37918325 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs534203618 | chr5:37918326-37918327 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs559269868 | chr5:37918363-37918364 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs192721855 | chr5:37918444-37918445 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
26 | rs533866131 | chr5:37918464-37918465 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs577644174 | chr5:37918548-37918549 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
28 | rs538430309 | chr5:37918565-37918566 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
29 | rs71604883 | chr5:37918597-37918598 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
30 | rs113436700 | chr5:37918598-37918599 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
31 | rs199566525 | chr5:37918614-37918615 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
32 | rs10524180 | chr5:37918620-37918621 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
33 | rs556762547 | chr5:37918628-37918629 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
34 | rs574935439 | chr5:37918629-37918630 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
35 | rs139356800 | chr5:37918630-37918631 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
36 | rs556184022 | chr5:37918649-37918650 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
37 | rs2216712 | chr5:37918703-37918704 | Weak transcription Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs142168931 | chr5:37918728-37918729 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
39 | rs2194230 | chr5:37918779-37918780 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
40 | rs202002001 | chr5:37918815-37918816 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
41 | rs5867374 | chr5:37918816-37918817 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
42 | rs112704898 | chr5:37918835-37918836 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
43 | rs2194229 | chr5:37918839-37918840 | Weak transcription Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs1035500 | chr5:37918856-37918857 | Weak transcription Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs115454722 | chr5:37918946-37918947 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs562663786 | chr5:37918947-37918948 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs117049202 | chr5:37918948-37918949 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs188047528 | chr5:37918997-37918998 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs566997251 | chr5:37918999-37919000 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs151165759 | chr5:37919105-37919106 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Myofibroblastic sarcoma | 19369631 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 16608533 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Intellectual disability | 22102821 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Prostate cancer | 18632612 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Breast cancer | 19553991 | CNVD |
Lung cancer | 19553991 | CNVD |
Melanoma | 19553991 | CNVD |
Ovarian cancer | 19553991 | CNVD |
Prostate cancer | 19553991 | CNVD |
Non-small cell lung cancer | 17156491 | CNVD |
Breast cancer | 17133270 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Breast cancer | 17393978 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Acute lymphoblastic leukemia | 17640729 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Lung cancer | 19153074 | CNVD |
Cornelia de Lange syndrome | 21085971 | CNVD |
Autism | 21701786 | CNVD |
Cervical cancer | 16585170 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 19197363 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:37915400-37926400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr5:37916400-37919400 | Weak transcription | Ovary | ovary |
3 | chr5:37917600-37919000 | Enhancers | Fetal Heart | heart |
4 | chr5:37917800-37918200 | Weak transcription | HMEC | breast |
5 | chr5:37918200-37918400 | Enhancers | HMEC | breast |
6 | chr5:37918200-37919400 | Enhancers | Colon Smooth Muscle | Colon |
7 | chr5:37918400-37919000 | Enhancers | Rectal Smooth Muscle | rectum |
8 | chr5:37918400-37926400 | Weak transcription | HMEC | breast |
9 | chr5:37919000-37919200 | Flanking Active TSS | Fetal Heart | heart |
10 | chr5:37919200-37919400 | Enhancers | Fetal Heart | heart |
11 | chr5:37919400-37919600 | Flanking Active TSS | Fetal Heart | heart |
12 | chr5:37919400-37919800 | Enhancers | Ovary | ovary |
13 | chr5:37919400-37919800 | Enhancers | Pancreas | Pancrea |
14 | chr5:37920600-37921000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
15 | chr5:37920800-37921600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
16 | chr5:37921400-37921600 | Enhancers | Fetal Heart | heart |